End-of-day quote
BURSA MALAYSIA
18:00:00 2024-05-05 EDT
|
5-day change
|
1st Jan Change
|
2.29
MYR
|
-0.43%
|
|
+9.05%
|
+23.78%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
5,320
|
11,498
|
4,899
|
2,807
|
4,720
|
5,843
|
-
|
-
|
Enterprise Value (EV)
1 |
5,736
|
10,981
|
2,594
|
818.7
|
3,471
|
4,120
|
4,092
|
4,136
|
P/E ratio
|
23.7
x
|
10.6
x
|
1.72
x
|
17.9
x
|
330
x
|
39.8
x
|
31.9
x
|
25.1
x
|
Yield
|
1.44%
|
3.11%
|
25%
|
2.27%
|
1.08%
|
0.93%
|
1.13%
|
1.48%
|
Capitalization / Revenue
|
2.39
x
|
3.15
x
|
0.74
x
|
1.21
x
|
2.98
x
|
2.9
x
|
2.48
x
|
2.21
x
|
EV / Revenue
|
2.58
x
|
3.01
x
|
0.39
x
|
0.35
x
|
2.19
x
|
2.05
x
|
1.73
x
|
1.57
x
|
EV / EBITDA
|
15
x
|
7
x
|
0.66
x
|
2.38
x
|
18.4
x
|
14.6
x
|
11.8
x
|
10
x
|
EV / FCF
|
74.5
x
|
13.6
x
|
1.44
x
|
-2.52
x
|
43.7
x
|
43.3
x
|
27.2
x
|
31.3
x
|
FCF Yield
|
1.34%
|
7.35%
|
69.4%
|
-39.7%
|
2.29%
|
2.31%
|
3.68%
|
3.2%
|
Price to Book
|
3.73
x
|
4.84
x
|
1.22
x
|
0.72
x
|
1.23
x
|
1.49
x
|
1.43
x
|
1.39
x
|
Nbr of stocks (in thousands)
|
2,557,872
|
2,555,120
|
2,551,620
|
2,551,620
|
2,551,620
|
2,551,620
|
-
|
-
|
Reference price
2 |
2.080
|
4.500
|
1.920
|
1.100
|
1.850
|
2.290
|
2.290
|
2.290
|
Announcement Date
|
20-02-21
|
21-02-16
|
22-02-17
|
23-02-16
|
24-02-22
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
2,222
|
3,654
|
6,657
|
2,316
|
1,586
|
2,012
|
2,359
|
2,638
|
EBITDA
1 |
381.8
|
1,570
|
3,919
|
343.9
|
189
|
282.3
|
347.4
|
413.1
|
EBIT
1 |
290.6
|
1,460
|
3,804
|
217.3
|
72.85
|
161.6
|
219.2
|
278
|
Operating Margin
|
13.08%
|
39.95%
|
57.14%
|
9.38%
|
4.59%
|
8.03%
|
9.29%
|
10.54%
|
Earnings before Tax (EBT)
1 |
280.1
|
1,445
|
3,748
|
212.9
|
35.85
|
203.6
|
254
|
324.7
|
Net income
1 |
224.8
|
1,087
|
2,854
|
156.6
|
14.22
|
154
|
190.7
|
240.9
|
Net margin
|
10.12%
|
29.75%
|
42.86%
|
6.76%
|
0.9%
|
7.65%
|
8.09%
|
9.13%
|
EPS
2 |
0.0879
|
0.4250
|
1.118
|
0.0614
|
0.005600
|
0.0575
|
0.0718
|
0.0911
|
Free Cash Flow
1 |
76.95
|
807.3
|
1,799
|
-324.7
|
79.35
|
95.1
|
150.4
|
132.3
|
FCF margin
|
3.46%
|
22.1%
|
27.03%
|
-14.02%
|
5%
|
4.73%
|
6.38%
|
5.01%
|
FCF Conversion (EBITDA)
|
20.15%
|
51.43%
|
45.91%
|
-
|
41.97%
|
33.69%
|
43.3%
|
32.02%
|
FCF Conversion (Net income)
|
34.23%
|
74.26%
|
63.06%
|
-
|
557.92%
|
61.77%
|
78.85%
|
54.9%
|
Dividend per Share
2 |
0.0300
|
0.1400
|
0.4800
|
0.0250
|
0.0200
|
0.0212
|
0.0260
|
0.0340
|
Announcement Date
|
20-02-21
|
21-02-16
|
22-02-17
|
23-02-16
|
24-02-22
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q3
|
2023 Q1
|
---|
Net sales
1 |
-
|
-
|
-
|
394.7
|
EBITDA
|
-
|
-
|
-
|
-
|
EBIT
1 |
-
|
-
|
-
|
-18.63
|
Operating Margin
|
-
|
-
|
-
|
-4.72%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-
|
-19.07
|
Net income
|
218.7
|
90.1
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
EPS
2 |
-
|
0.0353
|
0.009100
|
-0.009500
|
Dividend per Share
|
-
|
-
|
-
|
-
|
Announcement Date
|
22-02-17
|
22-04-27
|
22-11-02
|
23-04-27
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
415
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
517
|
2,305
|
1,988
|
1,249
|
1,723
|
1,751
|
1,707
|
Leverage (Debt/EBITDA)
|
1.088
x
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
77
|
807
|
1,799
|
-325
|
79.3
|
95.1
|
150
|
132
|
ROE (net income / shareholders' equity)
|
16.4%
|
57.1%
|
88.9%
|
3.96%
|
0.37%
|
3.72%
|
4.74%
|
5.68%
|
ROA (Net income/ Total Assets)
|
10%
|
36.7%
|
65.7%
|
3.33%
|
0.33%
|
3.22%
|
3.99%
|
4.15%
|
Assets
1 |
2,239
|
2,965
|
4,342
|
4,700
|
4,259
|
4,786
|
4,786
|
5,805
|
Book Value Per Share
2 |
0.5600
|
0.9300
|
1.580
|
1.520
|
1.500
|
1.540
|
1.600
|
1.650
|
Cash Flow per Share
2 |
0.1200
|
0.3800
|
0.7900
|
-0.0900
|
0.0700
|
0.0600
|
0.1000
|
0.1200
|
Capex
1 |
221
|
172
|
214
|
100
|
95.8
|
127
|
124
|
205
|
Capex / Sales
|
9.96%
|
4.7%
|
3.22%
|
4.33%
|
6.04%
|
6.31%
|
5.28%
|
7.77%
|
Announcement Date
|
20-02-21
|
21-02-16
|
22-02-17
|
23-02-16
|
24-02-22
|
-
|
-
|
-
|
Last Close Price
2.29
MYR Average target price
1.869
MYR Spread / Average Target -18.40% Consensus |
1st Jan change
|
Capi.
|
---|
| +23.78% | 1.24B | | +13.03% | 27.92B | | -29.30% | 3.08B | | -14.71% | 2.53B | | +21.58% | 2.47B | | +7.41% | 2.1B | | -3.87% | 1.91B | | +0.56% | 1.51B | | +2.24% | 1.34B | | +6.58% | 1.13B |
Medical Supplies
|